AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32114812 — intervention group
Group type: COMPARATOR
Intervention: Standard intramedullary nail (220 mm)
Number of subjects: 229
Study 35667085 — intervention group
Group type: EXPERIMENTAL
Intervention: 1300 mg TXA orally or 1000 mg TXA IV thrice daily for maximum 30 days
Number of subjects: 337
Study 35667085 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 337
Study 32342559 — intervention group
Group type: EXPERIMENTAL
Intervention: Esencia lens (progressive multifocal and reverse geometry SCL)
Number of subjects: 70
Study 32342559 — intervention group
Group type: COMPARATOR
Intervention: Conventional SCLs (control)
Number of subjects: 70
Study 33284465 — intervention group
Group type: EXPERIMENTAL
Intervention: EGUC system
Number of subjects: 60
Study 33284465 — intervention group
Group type: EXPERIMENTAL
Intervention: VAS
Number of subjects: 60
Study 33667677 — intervention group
Group type: EXPERIMENTAL
Intervention: H. pylori seroprevalence
Number of subjects: 16144
Study 33667677 — intervention group
Group type: EXPERIMENTAL
Intervention: H. pylori seroprevalence by U.S. born status
Number of subjects: 16144
Study 33667677 — intervention group
Group type: EXPERIMENTAL
Intervention: H. pylori seroprevalence by Hispanic/Latino background
Number of subjects: 16144
Study 33667677 — intervention group
Group type: EXPERIMENTAL
Intervention: H. pylori seroprevalence associated factors
Number of subjects: 16144
Study 33454398 — intervention group
Group type: EXPERIMENTAL
Intervention: Kinect based exergaming (EXER)
Number of subjects: 46
Study 33454398 — intervention group
Group type: COMPARATOR
Intervention: Combined physical exercise (CPE)
Number of subjects: 46
Study 33454398 — intervention group
Group type: EXPERIMENTAL
Intervention: Kinect based exergaming (EXER) and Combined physical exercise (CPE)
Number of subjects: 46
Study 32533249 — intervention group
Group type: EXPERIMENTAL
Intervention: Active frontotemporal tDCS (10 sessions)
Number of subjects: 17
Study 32593293 — intervention group
Group type: EXPERIMENTAL
Intervention: BCI-assisted hand motor imagery (MI) training
Number of subjects: 48
Study 32593293 — intervention group
Group type: COMPARATOR
Intervention: Hand motor imagery (MI) training not supported by BCI
Number of subjects: 48
Study 35954982 — intervention group
Group type: EXPERIMENTAL
Intervention: School-based cycling intervention program during Physical Education sessions
Number of subjects: 122
Study 35954982 — intervention group
Group type: EXPERIMENTAL
Intervention: School-based cycling intervention program
Number of subjects: 122
Study 33630873 — intervention group
Group type: EXPERIMENTAL
Intervention: WeChat feeding health education platform
Number of subjects: 1804
Study 33630873 — intervention group
Group type: COMPARATOR
Intervention: Standard feeding practices
Number of subjects: 1804
Study 33630873 — intervention group
Group type: COMPARATOR
Intervention: Standard information sources
Number of subjects: 1804
Study 32896294 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous iron (1000 mg ferric carboxymaltose in 100 mL normal saline, infusion over 15 min)
Number of subjects: 487
Study 32896294 — intervention group
Group type: COMPARATOR
Intervention: Placebo (100 mL normal saline, infusion over 15 min)
Number of subjects: 487
Study 32896294 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous iron
Number of subjects: 487
Study 32896294 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 487
Study 35939921 — intervention group
Group type: EXPERIMENTAL
Intervention: Paliperidone palmitate (PP)
Number of subjects: 235
Study 35939921 — intervention group
Group type: COMPARATOR
Intervention: Oral antipsychotics (OAPs)
Number of subjects: 235
Study 33590363 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulmonary metastasectomy
Number of subjects: 0
Study 33590363 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 32327339 — intervention group
Group type: EXPERIMENTAL
Intervention: Headless compression screws
Number of subjects: 27
Study 32327339 — intervention group
Group type: COMPARATOR
Intervention: Plate-and-screws
Number of subjects: 27
Study 32327339 — intervention group
Group type: COMPARATOR
Intervention: Pin plates
Number of subjects: 27
Study 36849056 — intervention group
Group type: EXPERIMENTAL
Intervention: AI‐EARS
Number of subjects: 12
Study 32770781 — intervention group
Group type: EXPERIMENTAL
Intervention: Tranexamic acid (TXA)
Number of subjects: 4079
Study 32770781 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4079
Study 32511682 — intervention group
Group type: EXPERIMENTAL
Intervention: Antibiotic prescribing at visits that met criteria (205 out of 214 visits, 96%)
Number of subjects: 425
Study 32511682 — intervention group
Group type: COMPARATOR
Intervention: Antibiotic prescribing at visits that did not meet criteria (193 out of 211 visits, 92%)
Number of subjects: 425
Study 35040920 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-day antibiotic treatment
Number of subjects: 380
Study 35040920 — intervention group
Group type: COMPARATOR
Intervention: 10-day antibiotic treatment
Number of subjects: 380
Study 34593076 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthy Caregivers-Healthy Children (HC2) intervention
Number of subjects: 24
Study 34593076 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 24
Study 32675598 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural group (10-mL solution of 50 mcg of Fentanyl, 0.125% Bupivacaine, and 0.9% saline solution)
Number of subjects: 45
Study 32675598 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural group
Number of subjects: 45
Study 32675598 — intervention group
Group type: COMPARATOR
Intervention: Control group (decompression alone)
Number of subjects: 45
Study 32675598 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 45
Study 36067389 — intervention group
Group type: EXPERIMENTAL
Intervention: Health problem (e.g., hypertension)
Number of subjects: 0
Study 36067389 — intervention group
Group type: COMPARATOR
Intervention: Healthy state (e.g., normal blood pressure)
Number of subjects: 0
Study 36067389 — intervention group
Group type: EXPERIMENTAL
Intervention: Addictive disorders
Number of subjects: 0
Study 36067389 — intervention group
Group type: EXPERIMENTAL
Intervention: Health problem
Number of subjects: 0
Study 33094406 — intervention group
Group type: EXPERIMENTAL
Intervention: Potassium oxalate mouth-rinse
Number of subjects: 155
Study 33094406 — intervention group
Group type: EXPERIMENTAL
Intervention: Arginine mouth-rinse
Number of subjects: 155
Study 33094406 — intervention group
Group type: EXPERIMENTAL
Intervention: Herbal extracts mouth-rinse
Number of subjects: 155
Study 33094406 — intervention group
Group type: COMPARATOR
Intervention: Control (no mouth-rinse)
Number of subjects: 155
Study 33185560 — intervention group
Group type: EXPERIMENTAL
Intervention: Overnight pulse oximetry
Number of subjects: 83
Study 33185560 — intervention group
Group type: COMPARATOR
Intervention: Once-daily pulse oximetry
Number of subjects: 83
Study 33185560 — intervention group
Group type: COMPARATOR
Intervention: Symptom monitoring
Number of subjects: 83
Study 33941098 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (0.5 ?g/kg) for 10 min before surgery infusion (Group D)
Number of subjects: 47
Study 33941098 — intervention group
Group type: COMPARATOR
Intervention: Saline infusion for 10 min before surgery (Group S)
Number of subjects: 47
Study 32284181 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotics group (1 g of Enterococcus faecium 129 BIO 3B-R, 3 times a day on postoperative days 1-5)
Number of subjects: 33
Study 32284181 — intervention group
Group type: COMPARATOR
Intervention: Non-probiotics group
Number of subjects: 33
Study 35016615 — intervention group
Group type: EXPERIMENTAL
Intervention: Group-based education (n=66)
Number of subjects: 130
Study 35016615 — intervention group
Group type: COMPARATOR
Intervention: Routine education in the celiac clinic (n=64)
Number of subjects: 130
Study 35550679 — intervention group
Group type: EXPERIMENTAL
Intervention: 2000 IU daily vitamin D3 for 12 weeks
Number of subjects: 132
Study 35550679 — intervention group
Group type: EXPERIMENTAL
Intervention: 60,000 IU weekly for 3 weeks
Number of subjects: 132
Study 35550679 — intervention group
Group type: EXPERIMENTAL
Intervention: 60,000 IU weekly for 6 weeks
Number of subjects: 132
Study 35088736 — intervention group
Group type: EXPERIMENTAL
Intervention: Real 1-Hz inhibitory rTMS to the right pars triangularis (PTr) for ten consecutive weekdays
Number of subjects: 26
Study 35088736 — intervention group
Group type: COMPARATOR
Intervention: Sham 1-Hz inhibitory rTMS to the right pars triangularis (PTr) for ten consecutive weekdays
Number of subjects: 26
Study 32303594 — intervention group
Group type: EXPERIMENTAL
Intervention: Salut Programme (universal child health promotion intervention)
Number of subjects: 0
Study 32303594 — intervention group
Group type: COMPARATOR
Intervention: Care-as-usual (control area)
Number of subjects: 0
Study 35641136 — intervention group
Group type: EXPERIMENTAL
Intervention: CDS Hooks prompts suggesting the use of 6 medical calculators in a SMART on FHIR medical reference app
Number of subjects: 70
Study 35641136 — intervention group
Group type: COMPARATOR
Intervention: Control group (no CDS Hooks prompts)
Number of subjects: 70
Study 35641136 — intervention group
Group type: EXPERIMENTAL
Intervention: CDS Hooks prompts
Number of subjects: 70
Study 34444289 — intervention group
Group type: EXPERIMENTAL
Intervention: Amaranth oil
Number of subjects: 44
Study 34444289 — intervention group
Group type: COMPARATOR
Intervention: Rapeseed oil
Number of subjects: 44
Study 33303445 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based patient decision aid (PtDA) for GAD
Number of subjects: 124
Study 33303445 — intervention group
Group type: COMPARATOR
Intervention: Fact sheet with general information on mental health
Number of subjects: 124
Study 35403286 — intervention group
Group type: COMPARATOR
Intervention: PPOIT
Number of subjects: 62
Study 35246232 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual focus group discussions
Number of subjects: 0
Study 33972334 — intervention group
Group type: EXPERIMENTAL
Intervention: Perampanel (titrated to 6 mg daily over 4 weeks)
Number of subjects: 328
Study 33972334 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 328
Study 33972334 — intervention group
Group type: EXPERIMENTAL
Intervention: Perampanel
Number of subjects: 328
Study 32075641 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulation by gaming (SG)
Number of subjects: 146
Study 32075641 — intervention group
Group type: COMPARATOR
Intervention: Traditional Teaching (TT)
Number of subjects: 146
Study 35088717 — intervention group
Group type: EXPERIMENTAL
Intervention: Threshold tracked short-interval intracortical inhibition (TT-SICI)
Number of subjects: 20
Study 35088717 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional short-interval intracortical inhibition (C-SICI)
Number of subjects: 20
Study 35088717 — intervention group
Group type: EXPERIMENTAL
Intervention: C-SICI
Number of subjects: 20
Study 35088717 — intervention group
Group type: EXPERIMENTAL
Intervention: TT-SICI
Number of subjects: 20
Study 34468987 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulation training using modified working casts
Number of subjects: 100
Study 34468987 — intervention group
Group type: COMPARATOR
Intervention: Control group (didactic instructions only)
Number of subjects: 100
Study 34050975 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual pedagogy
Number of subjects: 0
Study 34050975 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile based application (Brush Up)
Number of subjects: 0
Study 34050975 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 0
Study 32586348 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative ropivacaine block group
Number of subjects: 180
Study 32586348 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative ropivacaine block group
Number of subjects: 180
Study 32586348 — intervention group
Group type: COMPARATOR
Intervention: Nonblocking control group
Number of subjects: 180
Study 32586348 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 180
Study 33724079 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetically determined visceral adiposity (per 1 SD)
Number of subjects: 67
Study 33067055 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher levels of Ω‐6 fatty acids (AA, OA, AdA) at age 7 years
Number of subjects: 0
Study 33067055 — intervention group
Group type: EXPERIMENTAL
Intervention: Total Ω‐6 levels at age 16 years
Number of subjects: 0
Study 33067055 — intervention group
Group type: EXPERIMENTAL
Intervention: Total plasma Ω‐3 fatty acid levels
Number of subjects: 0
Study 33067055 — intervention group
Group type: EXPERIMENTAL
Intervention: Ω‐6/Ω‐3 ratio
Number of subjects: 0
Study 33067055 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetic instruments of total Ω‐3 or Ω‐6 levels
Number of subjects: 0
Study 32979642 — intervention group
Group type: EXPERIMENTAL
Intervention: Postextubation complications (overall, major, and minor)
Number of subjects: 240
Study 32979642 — intervention group
Group type: EXPERIMENTAL
Intervention: Major complications
Number of subjects: 240
Study 32979642 — intervention group
Group type: EXPERIMENTAL
Intervention: Extubation failure
Number of subjects: 240
Study 32979642 — intervention group
Group type: EXPERIMENTAL
Intervention: Postextubation complications
Number of subjects: 240
Study 35428359 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer coach intervention (CARE RA curriculum with assistance from a peer coach, weekly calls for 5 weeks)
Number of subjects: 0
Study 35428359 — intervention group
Group type: COMPARATOR
Intervention: Control (CARE RA curriculum without assistance)
Number of subjects: 0
Study 35428359 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer coach intervention
Number of subjects: 0
Study 35428359 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 0
Study 32032400 — intervention group
Group type: EXPERIMENTAL
Intervention: 100% autogenous bone (group AB)
Number of subjects: 8
Study 32032400 — intervention group
Group type: COMPARATOR
Intervention: 50% deproteinized bovine bone matrix (DBBM)/50% autogenous bone (group BOAB)
Number of subjects: 8
Study 35176844 — intervention group
Group type: EXPERIMENTAL
Intervention: Sinecatechins 10% ointment applied 3 times daily for 4 months after cryotherapy
Number of subjects: 55
Study 35176844 — intervention group
Group type: EXPERIMENTAL
Intervention: Sinecatechins 10% ointment
Number of subjects: 55
Study 33895598 — intervention group
Group type: EXPERIMENTAL
Intervention: Welcome Basket peer support intervention (1–2 sessions pre-discharge and weekly for a month post-discharge)
Number of subjects: 110
Study 33895598 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief version of the Welcome Basket intervention (1 community session post-discharge)
Number of subjects: 110
Study 33895598 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 110
Study 32607794 — intervention group
Group type: EXPERIMENTAL
Intervention: Postmenopausal women
Number of subjects: 81
Study 32607794 — intervention group
Group type: COMPARATOR
Intervention: Premenopausal women
Number of subjects: 81
Study 34448177 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational program (4 sessions at weekly intervals)
Number of subjects: 72
Study 34448177 — intervention group
Group type: COMPARATOR
Intervention: Routine diabetic care
Number of subjects: 72
Study 32693672 — intervention group
Group type: EXPERIMENTAL
Intervention: 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine
Number of subjects: 0
Study 32693672 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 37417644 — intervention group
Group type: EXPERIMENTAL
Intervention: HPE (plated)™ CALM Serum
Number of subjects: 18
Study 37417644 — intervention group
Group type: COMPARATOR
Intervention: Standard of care (Stratacel silicone gel)
Number of subjects: 18
Study 33413702 — intervention group
Group type: COMPARATOR
Intervention: Low RF (300 mg)
Number of subjects: 8
Study 33413702 — intervention group
Group type: EXPERIMENTAL
Intervention: Medium RF (600 mg)
Number of subjects: 8
Study 33413702 — intervention group
Group type: EXPERIMENTAL
Intervention: High RF (900 mg)
Number of subjects: 8
Study 33413702 — intervention group
Group type: EXPERIMENTAL
Intervention: All RF levels
Number of subjects: 8
Study 33543226 — intervention group
Group type: EXPERIMENTAL
Intervention: Transverse T‐shaped coronectomy
Number of subjects: 120
Study 33543226 — intervention group
Group type: COMPARATOR
Intervention: Longitudinal T‐shaped coronectomy
Number of subjects: 120
Study 33962510 — intervention group
Group type: EXPERIMENTAL
Intervention: Sheetali pranayama for 5 min (5 cycles)
Number of subjects: 60
Study 33962510 — intervention group
Group type: EXPERIMENTAL
Intervention: Sheetali pranayama
Number of subjects: 60
Study 33962510 — intervention group
Group type: COMPARATOR
Intervention: Normal breathing (control group)
Number of subjects: 60
Study 34288973 — intervention group
Group type: EXPERIMENTAL
Intervention: Botanical combination (soy isoflavone extract 100mg, Aframomum melegueta seed dry extract 50mg, Punica granatum skin dry extract 100mg)
Number of subjects: 57
Study 34288973 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 57
Study 34288973 — intervention group
Group type: EXPERIMENTAL
Intervention: Botanical combination
Number of subjects: 57
Study 32449530 — intervention group
Group type: EXPERIMENTAL
Intervention: Cranberry capsules (twice daily for 6 weeks)
Number of subjects: 210
Study 32449530 — intervention group
Group type: COMPARATOR
Intervention: Placebo (twice daily for 6 weeks)
Number of subjects: 210
Study 34093436 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise training (26 weeks of supervised treadmill training)
Number of subjects: 23
Study 33015869 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg saffron/daily
Number of subjects: 80
Study 33015869 — intervention group
Group type: COMPARATOR
Intervention: 100 mg maltodextrin/daily
Number of subjects: 80
Study 32709757 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (de novo uveitis patients receiving standard care)
Number of subjects: 466
Study 32517391 — intervention group
Group type: EXPERIMENTAL
Intervention: US-guided injection
Number of subjects: 62
Study 32517391 — intervention group
Group type: COMPARATOR
Intervention: TENS therapy
Number of subjects: 62
Study 32517391 — intervention group
Group type: COMPARATOR
Intervention: Sham TENS therapy
Number of subjects: 62
Study 35777699 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention (text message vaping cessation)
Number of subjects: 1829
Study 35777699 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 1829
Study 35777699 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention
Number of subjects: 1829
Study 33624044 — intervention group
Group type: EXPERIMENTAL
Intervention: Computerized decision support (CDS) system used during a randomly assigned 4-month period
Number of subjects: 2258
Study 33624044 — intervention group
Group type: COMPARATOR
Intervention: Control group (no CDS used)
Number of subjects: 2258
Study 33624044 — intervention group
Group type: EXPERIMENTAL
Intervention: CDS system
Number of subjects: 2258
Study 32418680 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutritional education program for four weeks
Number of subjects: 94
Study 35199165 — intervention group
Group type: EXPERIMENTAL
Intervention: gD‐2 HSV vaccine adjuvanted with ASO4
Number of subjects: 8323
Study 35199165 — intervention group
Group type: EXPERIMENTAL
Intervention: Neutralizing antibodies to HSV-1
Number of subjects: 8323
Study 35199165 — intervention group
Group type: EXPERIMENTAL
Intervention: Neutralizing antibodies to HSV-2
Number of subjects: 8323
Study 34919618 — intervention group
Group type: EXPERIMENTAL
Intervention: Extrashort (4-mm) implants
Number of subjects: 25
Study 34919618 — intervention group
Group type: COMPARATOR
Intervention: Conventional (≥ 8-mm) implants
Number of subjects: 25
Study 32418204 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 0
Study 32418204 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 35869682 — intervention group
Group type: EXPERIMENTAL
Intervention: TCI started with TBC set at 2.2 μg/ml
Number of subjects: 45
Study 35869682 — intervention group
Group type: EXPERIMENTAL
Intervention: TCI started with TBC set at 2.6 μg/ml
Number of subjects: 45
Study 35869682 — intervention group
Group type: EXPERIMENTAL
Intervention: TCI started with TBC set at 3.0 μg/ml
Number of subjects: 45
Study 34503548 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimally invasive distal pancreatectomy (MIDP)
Number of subjects: 258
Study 34503548 — intervention group
Group type: COMPARATOR
Intervention: Open distal pancreatectomy (ODP)
Number of subjects: 258
Study 32657920 — intervention group
Group type: EXPERIMENTAL
Intervention: Silicone-banded sleeve gastrectomy (BSG)
Number of subjects: 94
Study 32657920 — intervention group
Group type: COMPARATOR
Intervention: Nonbanded sleeve gastrectomy (SG)
Number of subjects: 94
Study 33430924 — intervention group
Group type: EXPERIMENTAL
Intervention: BIO101 (20-hydroxyecdysone) 350 mg b.i.d.
Number of subjects: 465
Study 33430924 — intervention group
Group type: COMPARATOR
Intervention: Placebo 350 mg b.i.d.
Number of subjects: 465
Study 32918767 — intervention group
Group type: EXPERIMENTAL
Intervention: 25(OH)D
Number of subjects: 326409
Study 32394777 — intervention group
Group type: EXPERIMENTAL
Intervention: CARET+CTI
Number of subjects: 131
Study 32394777 — intervention group
Group type: COMPARATOR
Intervention: Sham CARET+CTI
Number of subjects: 131
Study 35729592 — intervention group
Group type: EXPERIMENTAL
Intervention: New form of care with structured cooperation between medical geneticists and oncologists, case management, and telemedical genetic counseling.
Number of subjects: 2000
Study 35729592 — intervention group
Group type: COMPARATOR
Intervention: Routine care without structured cooperation or telemedical genetic counseling.
Number of subjects: 2000
Study 32665120 — intervention group
Group type: EXPERIMENTAL
Intervention: Polished zirconia (PZ) crowns
Number of subjects: 14
Study 32665120 — intervention group
Group type: EXPERIMENTAL
Intervention: Glazed zirconia (GZ) crowns
Number of subjects: 14
Study 32665120 — intervention group
Group type: COMPARATOR
Intervention: Natural enamel opposing natural enamel (NE-M)
Number of subjects: 14
Study 32665120 — intervention group
Group type: COMPARATOR
Intervention: Natural enamel opposing polished zirconia crowns (NE-PZ-M)
Number of subjects: 14
Study 32665120 — intervention group
Group type: COMPARATOR
Intervention: Natural enamel opposing glazed zirconia crowns (NE-GZ-M)
Number of subjects: 14